Cpwm, LLC Astrazeneca PLC Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cpwm, LLC holds 19,250 shares of AZN stock, worth $1.29 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

19,250

Previous 20,106 4.26%

Holding current value

$1.29 Million

Previous $1.33 Million 20.48%

% of portfolio

0.1%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $45,385 - $116,202	-856 Reduced 4.26%	19,250 $1.06 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $44,978 - $53,995	759 Added 3.92%	20,106 $1.33 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $6,407 - $7,718	115 Added 0.6%	19,347 $1.28 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $2,778 - $3,039	50 Added 0.26%	19,232 $1.16 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $10,942 - $13,600	226 Added 1.19%	19,182 $1.15 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $3,018 - $3,484	64 Added 0.34%	18,956 $942,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $3,299 - $3,945	-68 Reduced 0.36%	18,892 $944,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $1,114 - $1,283	21 Added 0.11%	18,960 $1.04 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $14,223 - $18,252	330 Added 1.77%	18,939 $1 Million
Q4 2018 Feb 08, 2019	SELL	$36.86 - $41.49 $442 - $497	-12 Reduced 0.06%	18,609 $707,000
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $1,877 - $2,144	54 Added 0.29%	18,621 $737,000
Q2 2018 Dec 21, 2018	BUY	$34.55 - $37.05 $641,489 - $687,907	18,567 New	18,567 $652,000
Q2 2018 Aug 09, 2018	SELL	$34.55 - $37.05 $641,489 - $687,907	-18,567 Closed	0 $0
Q1 2018 Dec 21, 2018	BUY	$32.97 - $36.63 $612,153 - $680,109	18,567 New	18,567 $649,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account